Back to Search
Start Over
Perrigo and Partner Cobrek Launch Generic Version of Evoclin and Announce Settlement of Related Litigation
- Source :
- Drug Week. April 23, 2010, 3106
- Publication Year :
- 2010
-
Abstract
- Perrigo Company (NASDAQ: PRGO) announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin [...]
- Subjects :
- United States. Food and Drug Administration
Drugs -- Product introduction
Antibacterial agents -- Product introduction
Anti-infective agents -- Product introduction
Phosphate industry -- Product introduction
Acne
Pharmaceuticals and cosmetics industries
Evoclin (Medication) -- Product introduction
Subjects
Details
- Language :
- English
- ISSN :
- 15316440
- Database :
- Gale General OneFile
- Journal :
- Drug Week
- Publication Type :
- News
- Accession number :
- edsgcl.223992280